SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Cyberonics (cybx) epilepsy therapy recommonded
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Dennis who wrote (332)5/20/1998 9:37:00 PM
From: fred woodall  Read Replies (1) of 471
 
Hello Dennis, Looks as if Cyberonics is going to have "in house" PR for
The NCP Device. Being that "Skip" knows what he's doing I consider it to be a good thing.

<Do they have enough cash? >
Cash isn't a problem. Several alternatives to sustain whatever promotional
Campaign/operating expenses, etc.

<Great recovery today on strong volume. Is this a dead cat bounce??>
Plenty of long term investors with substantial money have invested in CYBX at prices considerably higher than 15. I've been watching them float in since 21.5. Chance of positive news on the Co. to surface before earnings
is a high probability however if not a 13.5 support level would be a very speculative est. in a bear market.

I see the qualifications to satisfy the HCFA (Health Care Finance Administration) are rather demanding. Wonder what percentage of patients qualify? The NCP Device has been well publicized and those financially able were probably the first in line. Those financially burden & not meeting the HCFA requirements are left to other alternatives. Is this where the expansion/marketing comes in?

Anyone remember the Blue Cross Blue Shield recommendation a few months ago? I'm thinking those willing to invest 15k-50k last week might
have some future insight.

Fred

Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News